ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
848 Docetaxel (taxotere) as first line therapy for metastatic or recurrent soft tissue sarcoma (STS): A phase II trial
European Journal of Cancer
◽
10.1016/0959-8049(95)96097-w
◽
1995
◽
Vol 31
◽
pp. S177
◽
Cited By ~ 2
Author(s):
M.E. Blackstein
◽
E.A. Eisenhauer
◽
V. Bramwell
◽
K. Belanger
◽
S. Verma
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Trial
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Related Documents
Cited By
References
672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(03)90703-8
◽
2003
◽
Vol 1
(5)
◽
pp. S202
◽
Cited By ~ 15
Author(s):
J.-M. Extra
◽
F. Cognetti
◽
S. Chan
◽
D. Maraninchi
◽
R. Snyder
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
First Line
◽
Her2 Positive
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer
Cancer Research and Treatment
◽
10.4143/crt.2005.37.6.332
◽
2005
◽
Vol 37
(6)
◽
pp. 332
Author(s):
Nam-Su Lee
◽
Hee-Sook Park
◽
Jong-Ho Won
◽
Dae-Sik Hong
◽
Su-Taek Uh
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)
Lung Cancer
◽
10.1016/s0169-5002(99)90743-2
◽
1999
◽
Vol 25
◽
pp. S19-S20
Author(s):
M. O'Rourke
◽
D. Garfield
◽
P. Ellis
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer
The Oncologist
◽
10.1634/theoncologist.7-5-410
◽
2002
◽
Vol 7
(5)
◽
pp. 410-417
◽
Cited By ~ 107
Author(s):
Mohammad Jahanzeb
◽
Joanne E. Mortimer
◽
Furhan Yunus
◽
David H. Irwin
◽
James Speyer
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer
Tuberculosis and Respiratory Diseases
◽
10.4046/trd.2006.60.1.57
◽
2006
◽
Vol 60
(1)
◽
pp. 57
◽
Cited By ~ 1
Author(s):
Hye Cheol Jeong
◽
Sang Yeub Lee
◽
Jung Ha Kim
◽
Eun Sil Ha
◽
Jin Yong Jung
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
Head & Neck
◽
10.1002/hed.21884
◽
2011
◽
Vol 34
(9)
◽
pp. 1225-1230
◽
Cited By ~ 21
Author(s):
Daniel T. T. Chua
◽
Harry Ho-Yin Yiu
◽
Kasan Seetalarom
◽
Alice Wan-Ying Ng
◽
Johan Kurnianda
◽
...
Keyword(s):
Phase Ii
◽
Phase Ii Trial
◽
Nasopharyngeal Cancer
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.
10.1158/0008-5472.sabcs11-p1-14-01
◽
2011
◽
Author(s):
AD Seidman
◽
AK Conlin
◽
A Bach
◽
A Forero-Torres
◽
G Wright
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)
Annals of Oncology
◽
10.1016/j.annonc.2020.08.2247
◽
2020
◽
Vol 31
◽
pp. S1151
Author(s):
J. Albanell
◽
M.T.M. Martinez
◽
M. Ramos
◽
M.O.' Connor
◽
L. De la Cruz-Merino
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Postmenopausal Women
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Trial
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
Annals of Oncology
◽
10.1093/annonc/mdr450
◽
2012
◽
Vol 23
(6)
◽
pp. 1555-1561
◽
Cited By ~ 32
Author(s):
R. Houot
◽
S. Le Gouill
◽
M. Ojeda Uribe
◽
C. Mounier
◽
S. Courby
◽
...
Keyword(s):
Mantle Cell Lymphoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Mantle Cell
Download Full-text
Adjuvant chemotherapy with temozolomide and pegylated liposomal doxorubicin in the first-line therapy of patients with glioblastoma -a phase-II trial
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.1547
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 1547-1547
Author(s):
P. Hau
◽
T. Jauch
◽
B. Hirschmann
◽
E. Drechsel
◽
O. Grauer
◽
...
Keyword(s):
Adjuvant Chemotherapy
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Trial
◽
Pegylated Liposomal Doxorubicin
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close